Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

Wearables and healthcare

What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?

IGNIFI

- PMLiVE

Gates’ non-profit biotech for poverty diseases sets out its stall at BIO

Chief executive Heaton says GatesMRI will be a place where translational science meets medicine

- PMLiVE

Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat

Another BACE candidate is abandoned, leaving just one remaining in the pipeline

- PMLiVE

European pharma pips North America in remote physician engagement, according to Indegene-TEVA survey

European pharma companies have outperformed their American peers in applying remote physician engagement to their multi-channel marketing mix, according to the 2018 Indegene-TEVA survey. Among popular users, 35% of the...

- PMLiVE

Daily Brief: Tagrisso’s first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS

A rapid round up of today's pharma, biotech and healthcare news

- PMLiVE

Cancer Research UK to test Asterias’ lung cancer vaccine

The vaccine could treat NSCLC patients who are at risk of relapse

- PMLiVE

Biogen appoints executive VP, corporate development

Daniel Karp will also become a member of the executive committee

- PMLiVE

Exelixis appoints Andrew Peters to newly created position

He joins the biotech as its vice president, strategy

- PMLiVE

AbbVie, Roche get FDA OK for broader use of Venclexta

The drug is tipped to become a $2.5bn product by 2024

Patient outcomes in practice: delivering value that transforms lives

In this month’s PME, Lucid CEO and co-founder, Dennis O’Brien, and Managing Director, Louise Verrall, discuss ‘Patient outcomes in practice: delivering value that transforms lives’. In response to the increasing...

Lucid Group Communications Limited

Reaching the new influencers

With payers looking increasingly to real-world data, and to differentiation beyond this data through outcomes commitment and the provision of beyond the pill services, there’s never been a better time...

EU flag

UK pharma cheers EU science announcement

UK won't be excluded from Horizon research collaboration

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links